145 related articles for article (PubMed ID: 18524427)
1. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
Yuan X; Yang X; Cai D; Mao D; Wu J; Zong L; Liu J
Vaccine; 2008 Jul; 26(29-30):3727-34. PubMed ID: 18524427
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis.
Mao D; Kai G; Gaofu Q; Zheng Z; Li Z; Jie W; Jingjing L; Rongyue C
Vaccine; 2006 Jun; 24(23):4942-50. PubMed ID: 16697088
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
4. Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model.
Gaofu Q; Jun L; Xiuyun Z; Wentao L; Jie W; Jingjing L
Life Sci; 2005 Oct; 77(21):2690-702. PubMed ID: 15963532
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
[TBL] [Abstract][Full Text] [Related]
6. Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis.
Jun L; Jie L; Dongping Y; Xin Y; Taiming L; Rongyue C; Jie W; Jingjing L
Vaccine; 2012 Feb; 30(6):1029-37. PubMed ID: 22192848
[TBL] [Abstract][Full Text] [Related]
7. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
[TBL] [Abstract][Full Text] [Related]
8. [Intranasal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in gnotobiotic rats].
Guo J; Fan M; Bian Z; Jia R; Peng B
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):452-5. PubMed ID: 12641962
[TBL] [Abstract][Full Text] [Related]
9. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S
Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839
[TBL] [Abstract][Full Text] [Related]
11. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants.
Gaofu Q; Dan M; Jie W; Liao Z; Li Z; Roque RS; Jingjing L
Vaccine; 2004 Aug; 22(23-24):3187-94. PubMed ID: 15297073
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight chitosan in DNA vaccine delivery via mucosa.
Yang X; Yuan X; Cai D; Wang S; Zong L
Int J Pharm; 2009 Jun; 375(1-2):123-32. PubMed ID: 19481698
[TBL] [Abstract][Full Text] [Related]
14. Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis.
Long J; Lin J; Yang X; Yuan D; Wu J; Li T; Cao R; Liu J
Int Immunopharmacol; 2012 May; 13(1):82-7. PubMed ID: 22465386
[TBL] [Abstract][Full Text] [Related]
15. A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit.
Liaw YW; Lin CY; Lai YS; Yang TC; Wang CJ; Whang-Peng J; Liu LF; Lin CP; Nieh S; Lu SC; Hwang J
PLoS One; 2014; 9(12):e111529. PubMed ID: 25486007
[TBL] [Abstract][Full Text] [Related]
16. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
Bivas-Benita M; van Meijgaarden KE; Franken KL; Junginger HE; Borchard G; Ottenhoff TH; Geluk A
Vaccine; 2004 Apr; 22(13-14):1609-15. PubMed ID: 15068842
[TBL] [Abstract][Full Text] [Related]
18. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
Borges O; Tavares J; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Eur J Pharm Sci; 2007 Dec; 32(4-5):278-90. PubMed ID: 17884394
[TBL] [Abstract][Full Text] [Related]
20. [Construction of recombinant house dust mite group 1 allergen vaccine and study on immune response induced by nasal immunization].
Shi WD; Cao W; Liu Y; Xu Y; Tao ZZ; Dai Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):26-31. PubMed ID: 23656812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
